Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach (SY1)

4:45 – 6:00 pm
Wednesday, September 2
Non-CNE Symposia

Join us for this PeerView educational activity on neurofibromatosis type 1 (NF-1) and plexiform neurofibromas (PNs). An expert panel will provide insight into the expanding landscape of targeted therapies and will discuss optimal clinical decision-making for patients with NF-1 and NF-1─related PNs that are based on the latest evidence, best practice recommendations, and effective interdisciplinary collaboration. 

APHON thanks Astra Zeneca for their generous support of this event. 

All events during the 44th Annual Conference & Exhibit: A Virtual Experience will take place during Central Time.